SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome


Sabater L., Titulaer M., Saiz A., Verschuuren J., Guere A. O., Graus F.

NEUROLOGY, vol.70, no.12, pp.924-928, 2008 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 70 Issue: 12
  • Publication Date: 2008
  • Doi Number: 10.1212/01.wnl.0000281663.81079.24
  • Journal Name: NEUROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
  • Page Numbers: pp.924-928
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

Background/Objective: We reported that 43% of patients with Lambert-Eaton myasthenic syndrome (LEMS) and small cell lung cancer (SCLC) had an antibody called anti-glial nuclear antibody (AGNA), defined by the immunoreaction with the nuclei of the Bergmann glia of the cerebellum. This study was undertaken to identify the antigen recognized by AGNA and to confirm the association with paraneoplastic LEMS in a larger series.